Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3741691017 | Natamycin only product in ocular dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3741692012 | Product containing only natamycin in ocular dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Natamycin only product in ocular dose form | Is a | Product containing natamycin in ocular dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Natamycin only product in ocular dose form | Has manufactured dose form | Ocular dose form (dose form) | true | Inferred relationship | Some | ||
| Natamycin only product in ocular dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Natamycin only product in ocular dose form | Has active ingredient | Natamycin (substance) | true | Inferred relationship | Some | 1 | |
| Natamycin only product in ocular dose form | Is a | Natamycin only product | true | Inferred relationship | Some | ||
| Natamycin only product in ocular dose form | Plays role | Antifungal therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely natamycin 50 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | True | Natamycin only product in ocular dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR